India to United States: Pioglitazone Export Trade Route
India has recorded 718 verified shipments of Pioglitazone exported to United States, representing a combined trade value of $15.8M USD. This corridor is served by 4 active Indian exporters, with an average shipment value of $22.0K USD. The leading Indian exporter is AUROBINDO PHARMA LTD, which accounts for 54% of total export value with 269 shipments worth $8.5M USD. On the buying side, RISING PHARMA HOLDINGS, INC. is the largest importer in United States with $2.5M USD in purchases. The top 3 suppliers — AUROBINDO PHARMA LTD, AUROBINDO PHARMA LIMITED, MACLEODS PHARMACEUTICALS LTD — together control 92% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Pioglitazone corridor is one of India's established pharmaceutical export routes, with 718 shipments documented worth a combined $15.8M USD. The route is dominated by AUROBINDO PHARMA LTD, which alone accounts for roughly 54% of all export value, reflecting the consolidated nature of India's pioglitazone manufacturing sector.
Across 4 active suppliers, the average shipment value stands at $22.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (65%) and air (15%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during October–December, with an average transit time of 19 days port-to-port. The route has recorded an annual growth rate of 30.0%, placing it at rank #1 among India's top pioglitazone export destinations globally.
On the import side, key buyers of Indian pioglitazone in United States include RISING PHARMA HOLDINGS, INC., RISING PHARMA HOLDINGS INC, AUROLOGISTICS LLC (AUROBINDO PHARMA and 24 others. RISING PHARMA HOLDINGS, INC. is the single largest importer with 100 shipments valued at $2.5M USD.
Route Characteristics
- Average transit19 days
- Peak seasonQ4
- Primary modeMulti-modal
- Top portHYDERABAD ICD
Market Position
- Global rank#1
- Annual growth+30.0%
- Demand growth+25.1%
- Regulatory ease65/100
Top 10 Indian Pioglitazone Exporters to United States
Showing top 10 of 4 Indian suppliers exporting Pioglitazone to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | AUROBINDO PHARMA LTD Avg $31.5K per shipment | 269 | $8.5M | 53.6% |
| 2 | AUROBINDO PHARMA LIMITED Avg $34.3K per shipment | 112 | $3.8M | 24.3% |
| 3 | MACLEODS PHARMACEUTICALS LTD Avg $9.8K per shipment | 231 | $2.3M | 14.3% |
| 4 | MACLEODS PHARMACEUTICALS LIMITED Avg $11.5K per shipment | 106 | $1.2M | 7.7% |
This table shows the top 10 of 4 Indian companies exporting pioglitazone to United States, ranked by total trade value. The listed exporters are: AUROBINDO PHARMA LTD, AUROBINDO PHARMA LIMITED, MACLEODS PHARMACEUTICALS LTD, MACLEODS PHARMACEUTICALS LIMITED. AUROBINDO PHARMA LTD is the dominant supplier with 269 shipments worth $8.5M USD, giving it a 54% market share. The top 3 suppliers together account for 92% of the total trade value on this route.
Top 10 Pioglitazone Importers in United States
Showing top 10 of 27 known buyers in United States receiving Pioglitazone shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian pioglitazone in United States include RISING PHARMA HOLDINGS, INC., RISING PHARMA HOLDINGS INC, AUROLOGISTICS LLC (AUROBINDO PHARMA, NORTHSTAR DISTRIBUTION CENTER 8912, RISING PHARMA HOLDINGS, INC. ,., among 27 total buyers. The largest importer is RISING PHARMA HOLDINGS, INC., accounting for $2.5M USD across 100 shipments — representing 16% of all pioglitazone imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | RISING PHARMA HOLDINGS, INC. | 100 | $2.5M | 16.0% |
| 2 | RISING PHARMA HOLDINGS INC | 39 | $2.0M | 12.7% |
| 3 | AUROLOGISTICS LLC (AUROBINDO PHARMA | 61 | $1.9M | 12.2% |
| 4 | NORTHSTAR DISTRIBUTION CENTER 8912 | 150 | $1.4M | 9.0% |
| 5 | RISING PHARMA HOLDINGS, INC. ,. | 27 | $1.4M | 8.7% |
| 6 | AUROLOGISTICS LLC AUROBINDO PHARM | 25 | $919.3K | 5.8% |
| 7 | MACLEODS PHARMA USA INC | 74 | $896.9K | 5.7% |
| 8 | AUROLOGISTICS LLC, (AUROBINDO PHARM | 15 | $720.7K | 4.6% |
| 9 | AUROLOGISTICS LLC | 32 | $720.6K | 4.6% |
| 10 | MACLEODS PHARMA USA,INC | 33 | $687.3K | 4.4% |
Showing top 10 of 27 Pioglitazone importers in United States on this route.
Top 10 Pioglitazone Formulations Imported by United States
Showing top 10 of 410 product formulations shipped on the India to United States Pioglitazone route, ranked by trade value
United States imports a wide range of pioglitazone formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PIOGLITAZONE HYDROCHLORIDE TABLETS 30MG(PIOGLITAZONE TABLETS USP 30 MG) 500'S — accounts for $500.2K USD across 7 shipments. There are 410 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PIOGLITAZONE HYDROCHLORIDE TABLETS 30MG(PIOGLITAZONE TABLETS USP 30 MG) 500'S | 7 | $500.2K | 3.2% |
| 2 | PIOGLITAZONE HYDROCHLORIDE TABLETS 30MG(PIOGLITAZONE TABLETS USP 30 MG) 30'S | 5 | $309.6K | 2.0% |
| 3 | PIOGLITAZONE TABLETS 30 MG (29460X500'S) | 1 | $307.5K | 1.9% |
| 4 | PIOGLITAZONE TABLETS 30 MG (14674X500'S) | 2 | $303.4K | 1.9% |
| 5 | PIOGLITAZONE HYDROCHLORIDE TABLETS 45MGPIOGLITAZONE TABLETS USP 45 MG 30'S | 3 | $218.8K | 1.4% |
| 6 | PIOGLITAZONE HYDROCHLORIDE TABLETS 15MG | 6 | $205.8K | 1.3% |
| 7 | PIOGLITAZONE TABLETS 30 MG 18789X500'S | 1 | $196.1K | 1.2% |
| 8 | PIOGLITAZONE TABLETS 45 MG (11732X500 S) | 1 | $166.4K | 1.1% |
| 9 | PIOGLITAZONE TABLETS 30 MG (14736X500'S) | 3 | $153.8K | 1.0% |
| 10 | PIOGLITAZONE HYDROCHLORIDE TABLETS 30MGPIOGLITAZONE TABLETS USP 30 MG 500'S | 3 | $145.1K | 0.9% |
Showing top 10 of 410 Pioglitazone formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 65% sea for bulk, 15% air for urgent orders.
Top Ports of Origin
HYDERABAD ICD handles the highest volume with 185 shipments. Transit time averages 19 days by sea.
Market Dynamics
India's pioglitazone exports to United States are driven primarily by a handful of large-scale manufacturers. AUROBINDO PHARMA LTD with 269 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — AUROBINDO PHARMA LTD, AUROBINDO PHARMA LIMITED, MACLEODS PHARMACEUTICALS LTD — together account for 92% of total trade value on this route. The average shipment value of $22.0K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as pioglitazone hydrochloride tablets 30mg(pioglitazone tablets usp 30 mg) 30's and pioglitazone tablets 30 mg (29460x500's), suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, RISING PHARMA HOLDINGS, INC. is the largest importer with 100 shipments worth $2.5M USD — representing 16% of all pioglitazone imports from India on this route. A total of 27 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $15.8M
- Avg. Shipment
- $22.0K
- Suppliers
- 4
- Buyers
- 27
- Transit (Sea)
- ~19 days
- Annual Growth
- +30.0%
Related Analysis
Reverse Direction
United States → India — Pioglitazone (Import)Other Pioglitazone Routes
Unlock the Full India to United States Pioglitazone Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 718 shipments on this route.
Frequently Asked Questions — India to United States Pioglitazone Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Pioglitazone to United States?
The leading Indian exporters of Pioglitazone to United States are AUROBINDO PHARMA LTD, AUROBINDO PHARMA LIMITED, MACLEODS PHARMACEUTICALS LTD. AUROBINDO PHARMA LTD holds the largest market share at approximately 54% of total trade value on this route.
Q What is the total value of Pioglitazone exports from India to United States?
India exports Pioglitazone to United States worth approximately $15.8M USD across 718 recorded shipments. The average value per shipment is $22.0K USD.
Q Which ports does India use to ship Pioglitazone to United States?
The most active port of origin is HYDERABAD ICD with 185 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 65% of shipments going by sea and 15% by air.
Q How long does shipping take from India to United States for Pioglitazone?
The average transit time for Pioglitazone shipments from India to United States is approximately 19 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to United States Pioglitazone trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 30.0% with demand growth tracking at 25.1%. The route is ranked #1 among India's top Pioglitazone export destinations globally.
Q How many suppliers are active on the India to United States Pioglitazone route?
There are currently 4 active Indian suppliers exporting Pioglitazone to United States. The market is moderately concentrated with AUROBINDO PHARMA LTD accounting for 54% of total shipment value.
Q Who are the main importers of Pioglitazone from India in United States?
The leading importers of Indian Pioglitazone in United States include RISING PHARMA HOLDINGS, INC., RISING PHARMA HOLDINGS INC, AUROLOGISTICS LLC (AUROBINDO PHARMA, NORTHSTAR DISTRIBUTION CENTER 8912, RISING PHARMA HOLDINGS, INC. ,.. RISING PHARMA HOLDINGS, INC. is the largest buyer with 100 shipments worth $2.5M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Pioglitazone.
- 2.Supplier/Buyer Matching: 4 Indian exporters and 27 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 718 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
718 Verified Shipments
4 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists